Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) Assets Average (2022 - 2025)

Prime Medicine's Assets Average history spans 4 years, with the latest figure at $363.9 million for Q4 2025.

  • For Q4 2025, Assets Average rose 15.46% year-over-year to $363.9 million; the TTM value through Dec 2025 reached $363.9 million, up 15.46%, while the annual FY2025 figure was $320.1 million, 30.3% up from the prior year.
  • Assets Average reached $363.9 million in Q4 2025 per PRME's latest filing, up from $332.0 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $363.9 million in Q4 2025 to a low of $216.5 million in Q4 2023.
  • Average Assets Average over 4 years is $297.2 million, with a median of $298.9 million recorded in 2023.
  • The largest YoY upside for Assets Average was 45.57% in 2024 against a maximum downside of 25.4% in 2024.
  • A 4-year view of Assets Average shows it stood at $287.8 million in 2022, then decreased by 24.77% to $216.5 million in 2023, then surged by 45.57% to $315.1 million in 2024, then rose by 15.46% to $363.9 million in 2025.
  • Per Business Quant, the three most recent readings for PRME's Assets Average are $363.9 million (Q4 2025), $332.0 million (Q3 2025), and $303.6 million (Q2 2025).